AVITA reported second quarter 2025 results and revised its 2025 guidance, stating that the Company experienced a “significant headwind from a temporary gap in Medicare Administrative Contractor (MAC) payments to providers for the use of our flagship RECELL® System, which led to a weakening in demand. Multiple MACs initiated payments in July with resolution expected in Q3.”
Following this report, the price of the Company’s stock dropped on August 7, 2025.
To receive more information, please fill out the form.
